<scp>PHAREO</scp> study: Perceived and observed accessibility to therapeutic drugs used for treating patients with inherited bleeding disorders-Reference-Cited by-同舟云学术

PHAREO study: Perceived and observed accessibility to therapeutic drugs used for treating patients with inherited bleeding disorders

Published:2022-06-20 Issue:10 Volume:47 Page:1667-1675
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Chamouard Valérie¹²,Fraticelli Laurie³⁴^ORCID,Freyssenge Julie³⁵,Claustre Clément³,Négrier Claude¹,El Khoury Carlos³⁶,

Affiliation:

1. Centre de Référence de l'Hémophilie et autres déficits constitutionnels en protéines de la coagulation, Hôpital Louis Pradel Groupement Hospitalier Est Bron France

2. Service pharmaceutique, Hôpital Louis Pradel Groupement Hospitalier Est Bron France

3. RESCUe‐RESUVal, Centre Hospitalier Lucien Hussel Montée Docteur Maurice Chapuis Vienne France

4. Laboratoire Parcours Santé Systémique (P2S) UR 4129 Université de Lyon 1 Lyon France

5. Research On Healthcare Performance (RESHAPE) INSERM Lyon France

6. Clinical Research Unit Médipôle Hôpital Mutualiste Villeurbanne France

Funder

Hospices Civils de Lyon

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13718

Reference23 articles.

1. Various regimens for prophylactic treatment of patients with haemophilia

2. Aspects of prophylactic treatment of hemophilia

3. The availability of new drugs for hemophilia treatment

4. Haemophilia Care in Europe: the ESCHQoL study

5. Disparities in access to trauma care in the United States: A population-based analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of access to emicizumab (Hemlibra®) for people with haemophilia A in community and hospital pharmacies in France;European Journal of Public Health;2024-08-29

2. Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study;JMIR Formative Research;2024-04-04

3. Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study (Preprint);2023-11-17

4. Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey;Haemophilia;2023-09-17

5. Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model;JMIR Research Protocols;2023-03-08